Combined Risk Stratification With Patient Characteristics and Biomarkers in Patients Treated With the Impella for Cardiogenic Shock
Background In patients with cardiogenic shock (CS), a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory support. Given the high morbidity and mortality in this patient population, early risk stratification is relevant w...
Saved in:
| Main Authors: | Yuichi Saito, Yuki Shiko, Kazuya Tateishi, Koichi Toda, Goro Matsumiya, Yoshio Kobayashi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.040487 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impella malrotation affects left ventricle unloading in cardiogenic shock patients
by: Luca Baldetti, et al.
Published: (2025-02-01) -
Combined mechanical circulatory support (Impella + ECMO) in cardiogenic shock caused by fulminant myocarditis
by: Michaela Zemkova, et al.
Published: (2025-02-01) -
Protocol‐Driven Best Practices and Cardiogenic Shock Survival in Asian Patients
by: Calvin Leung, et al.
Published: (2025-03-01) -
Cardiogenic shock — the current state of the problem
by: S. A. Boytsov, et al.
Published: (2019-11-01) -
Implications of mechanical circulatory support devices in a pregnant woman with cardiogenic shock
by: Johanna A. van der Zande, et al.
Published: (2025-01-01)